This unique book offers a methodical exploration of biological, social, and ethical topics on the treatment (or lack thereof) of psychotic brain disease. Part I provides an empirical engagement with neuroscience and covers the neurobiology and pharmacology of schizophrenia, providing the reader with a current understanding of the disease. Topic areas include anosognosia, community treatments, and early intervention. Part II looks at international policy approaches to schizophrenia featuring topics such as the policy, funding, and historical elements contributing to frequently misguided approaches to severe brain disease, and it explains why some societies won't/can't support human beings with psychotic disease. Part III focuses on neuroethics and asks: 'What is right?' through chapters discussing the concepts of consciousness and free will, as well as the principles of nonmaleficence, beneficence, autonomy, and justice. Collectively the comprehensive approach of this book allows the reader to gain a full understanding of the ethical and clinical complexities in treating schizophrenia.
Loading metrics...
* Views captured on Cambridge Core between #date#. This data will be updated every 24 hours.
Usage data cannot currently be displayed.
This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.
The HTML of this book complies with version 2.1 of the Web Content Accessibility Guidelines (WCAG), covering newer accessibility requirements and improved user experiences and achieves the intermediate (AA) level of WCAG compliance, covering a wider range of accessibility requirements.
Allows you to navigate directly to chapters, sections, or non‐text items through a linked table of contents, reducing the need for extensive scrolling.
Provides an interactive index, letting you go straight to where a term or subject appears in the text without manual searching.
You will encounter all content (including footnotes, captions, etc.) in a clear, sequential flow, making it easier to follow with assistive tools like screen readers.
You get concise descriptions (for images, charts, or media clips), ensuring you do not miss crucial information when visual or audio elements are not accessible.
You get more than just short alt text: you have comprehensive text equivalents, transcripts, captions, or audio descriptions for substantial non‐text content, which is especially helpful for complex visuals or multimedia.
You will still understand key ideas or prompts without relying solely on colour, which is especially helpful if you have colour vision deficiencies.
You gain clarity from ARIA (Accessible Rich Internet Applications) roles and attributes, as they help assistive technologies interpret how each part of the content functions.